Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Inula racemosa
Himalayan relative of elecampane used in Ayurveda for cardiovascular and respiratory conditions.
Pushkarmool (Inula racemosa) is a Himalayan herb traditionally used in Ayurveda for cardiovascular and respiratory conditions, including angina and bronchial asthma. Its primary active compounds are sesquiterpene lactones such as alantolactone and isoalantolactone, along with inulin and helenin, which contribute to its anti-inflammatory, bronchodilatory, and cardioprotective effects. Modern research supports its use as a cardiac tonic and anti-anginal agent, though evidence remains limited to pilot and small clinical trials.
Alantolactone and isoalantolactone inhibit the NF-κB pathway, reducing pro-inflammatory cytokine production and oxidative stress. These compounds also exhibit positive inotropic and coronary vasodilatory effects, likely through calcium channel modulation and phosphodiesterase inhibition, improving myocardial oxygen supply. Additionally, the herb stimulates bronchial secretions via reflex vagal activation, providing expectorant and bronchodilatory actions in respiratory conditions.
Himalayan relative of elecampane used in Ayurveda for cardiovascular and respiratory conditions.
Pushkarmool (Inula racemosa) is a Himalayan herb traditionally used in Ayurveda for cardiovascular and respiratory conditions, including angina and bronchial asthma. Its primary active compounds are sesquiterpene lactones such as alantolactone and isoalantolactone, along with inulin and helenin, which contribute to its anti-inflammatory, bronchodilatory, and cardioprotective effects. Modern research supports its use as a cardiac tonic and anti-anginal agent, though evidence remains limited to pilot and small clinical trials.
Alantolactone and isoalantolactone inhibit the NF-κB pathway, reducing pro-inflammatory cytokine production and oxidative stress. These compounds also exhibit positive inotropic and coronary vasodilatory effects, likely through calcium channel modulation and phosphodiesterase inhibition, improving myocardial oxygen supply. Additionally, the herb stimulates bronchial secretions via reflex vagal activation, providing expectorant and bronchodilatory actions in respiratory conditions.